Literature DB >> 21496892

Safety of investigative bronchoscopy in the Severe Asthma Research Program.

Wendy C Moore1, Michael D Evans, Eugene R Bleecker, William W Busse, William J Calhoun, Mario Castro, Kian Fan Chung, Serpil C Erzurum, Douglas Curran-Everett, Raed A Dweik, Benjamin Gaston, Mark Hew, Elliot Israel, Martin L Mayse, Rodolfo M Pascual, Stephen P Peters, Lori Silveira, Sally E Wenzel, Nizar N Jarjour.   

Abstract

BACKGROUND: Investigative bronchoscopy was performed in a subset of participants in the Severe Asthma Research Program to gain insights into the pathobiology of severe disease. We evaluated the safety aspects of this procedure in this cohort with specific focus on patients with severe asthma.
OBJECTIVE: To evaluate prospectively changes in lung function and the frequency of adverse events related to investigative bronchoscopy.
METHODS: Bronchoscopy was performed by using a common manual of procedures. A subset of very severe asthma was defined by severe airflow obstruction, chronic oral corticosteroid use, and recent asthma exacerbations. Subjects were monitored for changes in lung function and contacted by telephone for 3 days after the procedure.
RESULTS: A total of 436 subjects underwent bronchoscopy (97 normal, 196 not severe, 102 severe, and 41 very severe asthma). Nine subjects were evaluated in hospital settings after bronchoscopy; 7 of these were respiratory-related events. Recent emergency department visits, chronic oral corticosteroid use, and a history of pneumonia were more frequent in subjects who had asthma exacerbations after bronchoscopy. The fall in FEV₁ after bronchoscopy was similar in the severe and milder asthma groups. Prebronchodilator FEV₁ was the strongest predictor of change in FEV₁ after bronchoscopy with larger decreases observed in subjects with better lung function.
CONCLUSION: Bronchoscopy in subjects with severe asthma was well tolerated. Asthma exacerbations were rare, and reduction in pulmonary function after the procedure was similar to that in subjects with less severe asthma. With proper precautions, investigative bronchoscopy can be performed safely in severe asthma.
Copyright © 2011 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21496892      PMCID: PMC3149754          DOI: 10.1016/j.jaci.2011.02.042

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  15 in total

Review 1.  Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2000-12       Impact factor: 21.405

2.  Safety of bronchoalveolar lavage and bronchial biopsies in patients with asthma of variable severity.

Authors:  T Van Vyve; P Chanez; J Bousquet; J Y Lacoste; F B Michel; P Godard
Journal:  Am Rev Respir Dis       Date:  1992-07

3.  Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program.

Authors:  Wendy C Moore; Eugene R Bleecker; Douglas Curran-Everett; Serpil C Erzurum; Bill T Ameredes; Leonard Bacharier; William J Calhoun; Mario Castro; Kian Fan Chung; Melissa P Clark; Raed A Dweik; Anne M Fitzpatrick; Benjamin Gaston; Mark Hew; Iftikhar Hussain; Nizar N Jarjour; Elliot Israel; Bruce D Levy; James R Murphy; Stephen P Peters; W Gerald Teague; Deborah A Meyers; William W Busse; Sally E Wenzel
Journal:  J Allergy Clin Immunol       Date:  2007-02       Impact factor: 10.793

4.  Workshop summary and guidelines: investigative use of bronchoscopy, lavage, and bronchial biopsies in asthma and other airway diseases.

Authors: 
Journal:  J Allergy Clin Immunol       Date:  1991-11       Impact factor: 10.793

5.  Safety of fibreoptic bronchoscopy in asthmatic and control subjects and effect on asthma control over two weeks.

Authors:  M Humbert; D S Robinson; B Assoufi; A B Kay; S R Durham
Journal:  Thorax       Date:  1996-07       Impact factor: 9.139

6.  National Institutes of Health workshop summary. Summary and recommendations of a workshop on the investigative use of fiberoptic bronchoscopy and bronchoalveolar lavage in individuals with asthma.

Authors: 
Journal:  J Allergy Clin Immunol       Date:  1985-08       Impact factor: 10.793

7.  The safety aspects of fiberoptic bronchoscopy, bronchoalveolar lavage, and endobronchial biopsy in asthma.

Authors:  R Djukanović; J W Wilson; C K Lai; S T Holgate; P H Howarth
Journal:  Am Rev Respir Dis       Date:  1991-04

Review 8.  Investigative bronchoprovocation and bronchoscopy in airway diseases.

Authors:  William W Busse; Adam Wanner; Kenneth Adams; Herbert Y Reynolds; Mario Castro; Badrul Chowdhury; Monica Kraft; Robert J Levine; Stephen P Peters; Eugene J Sullivan
Journal:  Am J Respir Crit Care Med       Date:  2005-07-14       Impact factor: 21.405

9.  Safety of research bronchoscopy, biopsy and bronchoalveolar lavage in asthma.

Authors:  W J Elston; A J Whittaker; L N Khan; P Flood-Page; C Ramsay; P K Jeffery; N C Barnes
Journal:  Eur Respir J       Date:  2004-09       Impact factor: 16.671

10.  Global strategy for asthma management and prevention: GINA executive summary.

Authors:  E D Bateman; S S Hurd; P J Barnes; J Bousquet; J M Drazen; J M FitzGerald; P Gibson; K Ohta; P O'Byrne; S E Pedersen; E Pizzichini; S D Sullivan; S E Wenzel; H J Zar
Journal:  Eur Respir J       Date:  2008-01       Impact factor: 16.671

View more
  21 in total

1.  Severe Asthma: The Evolution of Patient-directed Management.

Authors:  Michael Keller; David Kamp
Journal:  Clin Pulm Med       Date:  2014-01-01

2.  BAL Cell Gene Expression in Severe Asthma Reveals Mechanisms of Severe Disease and Influences of Medications.

Authors:  Nathaniel Weathington; Michael E O'Brien; Josiah Radder; Thomas C Whisenant; Eugene R Bleecker; William W Busse; Serpil C Erzurum; Benjamin Gaston; Annette T Hastie; Nizar N Jarjour; Deborah A Meyers; Jadranka Milosevic; Wendy C Moore; John R Tedrow; John B Trudeau; Hesper P Wong; Wei Wu; Naftali Kaminski; Sally E Wenzel; Brian D Modena
Journal:  Am J Respir Crit Care Med       Date:  2019-10-01       Impact factor: 21.405

3.  Epithelial eotaxin-2 and eotaxin-3 expression: relation to asthma severity, luminal eosinophilia and age at onset.

Authors:  John M Coleman; Chetan Naik; Fernando Holguin; Anuradha Ray; Prabir Ray; John B Trudeau; Sally E Wenzel
Journal:  Thorax       Date:  2012-09-26       Impact factor: 9.139

4.  Phenotype of asthmatics with increased airway S-nitrosoglutathione reductase activity.

Authors:  Nadzeya V Marozkina; Xin-Qun Wang; Vitali Stsiapura; Anne Fitzpatrick; Silvia Carraro; Gregory A Hawkins; Eugene Bleecker; Deborah Meyers; Nizar Jarjour; Sean B Fain; Sally Wenzel; William Busse; Mario Castro; Reynold A Panettieri; Wendy Moore; Stephen J Lewis; Lisa A Palmer; Talissa Altes; Eduard E de Lange; Serpil Erzurum; W Gerald Teague; Benjamin Gaston
Journal:  Eur Respir J       Date:  2014-10-30       Impact factor: 16.671

5.  Severe asthma: lessons learned from the National Heart, Lung, and Blood Institute Severe Asthma Research Program.

Authors:  Nizar N Jarjour; Serpil C Erzurum; Eugene R Bleecker; William J Calhoun; Mario Castro; Suzy A A Comhair; Kian Fan Chung; Douglas Curran-Everett; Raed A Dweik; Sean B Fain; Anne M Fitzpatrick; Benjamin M Gaston; Elliot Israel; Annette Hastie; Eric A Hoffman; Fernando Holguin; Bruce D Levy; Deborah A Meyers; Wendy C Moore; Stephen P Peters; Ronald L Sorkness; W Gerald Teague; Sally E Wenzel; William W Busse
Journal:  Am J Respir Crit Care Med       Date:  2011-11-17       Impact factor: 21.405

Review 6.  Severe Asthma in Children: Lessons Learned and Future Directions.

Authors:  Anne M Fitzpatrick
Journal:  J Allergy Clin Immunol Pract       Date:  2016 Jan-Feb

7.  Prostaglandin D₂ pathway upregulation: relation to asthma severity, control, and TH2 inflammation.

Authors:  Merritt L Fajt; Stacy L Gelhaus; Bruce Freeman; Crystal E Uvalle; John B Trudeau; Fernando Holguin; Sally E Wenzel
Journal:  J Allergy Clin Immunol       Date:  2013-03-16       Impact factor: 10.793

8.  Mucociliary Clearance Differs in Mild Asthma by Levels of Type 2 Inflammation.

Authors:  Timothy E Corcoran; Alex S Huber; Sherri L Hill; Landon W Locke; Lawrence Weber; Ashok Muthukrishnan; Elisa M Heidrich; Sally Wenzel; Mike M Myerburg
Journal:  Chest       Date:  2021-05-21       Impact factor: 9.410

9.  Safety and Tolerability of Comprehensive Research Bronchoscopy in Chronic Obstructive Pulmonary Disease. Results from the SPIROMICS Bronchoscopy Substudy.

Authors:  J Michael Wells; Douglas A Arenberg; Igor Barjaktarevic; Surya P Bhatt; Russell P Bowler; Stephanie A Christenson; David J Couper; Mark T Dransfield; MeiLan K Han; Eric A Hoffman; Robert J Kaner; Victor Kim; Eric Kleerup; Fernando J Martinez; Wendy C Moore; Sarah L O'Beirne; Robert Paine; Nirupama Putcha; Sanjeev M Raman; R Graham Barr; Stephen I Rennard; Prescott G Woodruff; Jeffrey L Curtis
Journal:  Ann Am Thorac Soc       Date:  2019-04

10.  Safety of and cellular response to segmental bronchoprovocation in allergic asthma.

Authors:  Loren C Denlinger; Elizabeth A B Kelly; Ann M Dodge; John G McCartney; Keith C Meyer; Richard D Cornwell; Mary Jo Jackson; Michael D Evans; Nizar N Jarjour
Journal:  PLoS One       Date:  2013-01-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.